newsfilter
← Latest News
GlobeNewswire·

Conavi Medical Announces New Grants of Stock Options

CNVIF
  • Conavi Medical Corp. granted 1,600,000 stock options to company officers under its Omnibus Equity Incentive Plan on October 19, 2026.
  • The options are exercisable at C$0.20 per share with a ten-year term from the grant date.
  • Vesting occurs over four years, with 25% vesting on the first anniversary & the remaining 75% vesting in equal monthly installments over the subsequent 36 months.
  • The grant remains subject to approval by the TSX Venture Exchange.
  • Conavi Medical designs, manufactures, & markets a patented hybrid imaging system that co-registers IVUS & OCT beams for coronary artery procedures.
  • The company's hybrid imaging system holds 510(k) clearance from the U.S. Food and Drug Administration.